Aktien Sensor

AbbVie Inc has announced positive results from its TEMPLE study, showing that its oral migraine prevention drug atogepant is effective in reducing migraine frequency and may offer a new treatment option.

Fresenius SE & Co KGaA’s stock price has declined, but its long-term prospects remain bright due to its diversified product portfolio and strong presence in the healthcare industry.

Merck KGaA has awarded a grant to Neoclease, a startup focused on Parkinson’s disease research, to support the development of its AI-designed gene-editing platform.

McKesson Corp has seen a boost in investor confidence due to revised price targets from Morgan Stanley and Wells Fargo, driven by the company’s promising earnings growth prospects.

Teva Pharmaceutical Industries has formed a strategic partnership with Fosun Pharma to develop a revolutionary new cancer therapy, marking a bold leap forward in the pharmaceutical industry.

Sandoz Group AG is poised to capitalize on the growing demand for affordable treatment options, with the global biosimilars market expected to reach a valuation of over $72 billion by 2035.

WuXi AppTec’s stock price has declined by 6.32% on the Hong Kong Stock Exchange, despite the company’s recognition for sustainability and corporate governance efforts.

Terumo Corporation has partnered with MedHub-AI to market AI-based FFR technology in Japan, aiming to improve coronary physiology assessment and drive growth in the patient temperature monitoring market.

Sartorius Stedim Biotech embarks on a strategic expansion in France, bolstering its manufacturing and R&D capabilities and solidifying its position as a leader in the biotechnology sector.

Elevance Health Inc.’s stock price has fluctuated over the past few years, with recent stability despite a pending class action lawsuit alleging securities fraud.